Cargando…
The Effective Control of Hyperuricemia in Cancer Patients: A New Recombinant Conjugated Variant of Urate Oxidase
OBJECTIVE: Management of hyperuricemia is crucial to controlling tumor lysis syndrome (TLS) during cancer therapy. Urate oxidase (UOX) that catalyzes the enzymatic oxidation of uric acid into allantoin, is effective in lowering plasma uric acid levels and controlling hyperuricemia. Recently, we deve...
Autores principales: | Najjari, Abbas, Shahbazmohammadi, Hamid, Omidinia, Eskandar, Movafagh, Abolfazl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190373/ https://www.ncbi.nlm.nih.gov/pubmed/33639683 http://dx.doi.org/10.31557/APJCP.2021.22.2.627 |
Ejemplares similares
-
PASylated Urate
Oxidase Enzyme: Enhancing Biocatalytic
Activity, Physicochemical Properties, and Plasma Half-Life
por: Najjari, Abbas, et al.
Publicado: (2022) -
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
por: Pession, Andrea, et al.
Publicado: (2008) -
Computational Approach for Rational Design of Fusion Uricase with PAS Sequences
por: Najjari, Abbas, et al.
Publicado: (2020) -
Catalysis and Structure of Zebrafish Urate Oxidase Provide Insights into the Origin of Hyperuricemia in Hominoids
por: Marchetti, Marialaura, et al.
Publicado: (2016) -
Molecular Elucidation of a Urate Oxidase from Deinococcus radiodurans for Hyperuricemia and Gout Therapy
por: Chiu, Yi-Chih, et al.
Publicado: (2021)